Jolanta B. Perz

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Michael Stadler, Martin Bornhäuser, Gesine Bug et al. · Blood · 2005 · 199 citations · Full text

Medicine, Molecular Biology, Oncology +13

Non-Invasive Predictors of Survival in Cardiac Amyloidosis

Arnt V. Kristen, Jolanta B. Perz, Stefan Schönland et al. · European Journal of Heart Failure · 2007 · 127 citations

Medicine, Biomedical Sciences, Cardiology +13

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

Eduardo Olavarría, Shamyla Siddique, Sharon Avery et al. · Blood · 2007 · 110 citations · Full text

Life Sciences, Hematology, Immunology +16

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients

Derville O’Shea, Chrissy Giles, Evangelos Terpos et al. · Bone Marrow Transplantation · 2006 · 109 citations

Medicine, Hematology, Surgery +16

High‐dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study

Jolanta B. Perz, Stefan Schönland, Michael Hundemer et al. · British Journal of Haematology · 2004 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17